Deutsche Bank’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Deutsche Bank’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16,961	Closed	-$68.7K	–	3709
2023 Q4	$68.7K	Buy	16,961 +16,091	+1,850%	+$49.1K	﹤0.01%	3368
2023 Q3	$2.34K	Sell	870 -7,104	-89%	-$27.8K	﹤0.01%	3635
2023 Q2	$74.4K	Sell	7,974 -2,670	-25%	-$26.3K	﹤0.01%	3382
2023 Q1	$94.5K	Buy	10,644 +1,122	+12%	+$11K	﹤0.01%	3352
2022 Q4	$47.4K	Buy	9,522 +112	+1%	+$656	﹤0.01%	3591
2022 Q3	$55K	Sell	9,410 -1,139	-11%	-$8.05K	﹤0.01%	3565
2022 Q2	$58K	Buy	10,549 +4,296	+69%	+$35.5K	﹤0.01%	3715
2022 Q1	$72K	Sell	6,253 -740	-11%	-$7.91K	﹤0.01%	3703
2021 Q4	$89K	Buy	+6,993	New	+$106K	﹤0.01%	3755

Deutsche Bank's THRX Position: Q1 2024 in Review

Deutsche Bank sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 16,961 shares — an estimated $68.7K sold.

Deutsche Bank first reported a position in THRX in Q4 2021 and held it in 9 quarters. The position peaked at $94.5K in Q1 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Deutsche Bank reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Deutsche Bank sold 16,961 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $68.7K.
Deutsche Bank first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
Deutsche Bank's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $94.5K in Q1 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Deutsche Bank's 13F filing for Q1 2024, filed 15 May 2024.